Decreased catecholamine-induced cell death in B lymphocytes from patients with rheumatoid arthritis

被引:11
作者
Wahle, M
Pierer, M
Krause, A
Kölker, S
Baerwald, CGO
机构
[1] Univ Hosp Leipzig, Dept Med 4, D-04107 Leipzig, Germany
[2] Humboldt Univ, Charite Univ Hosp, Dept Rheumatol & Clin Immunol, Berlin, Germany
[3] Univ Heidelberg, Childrens Hosp, Div Metab & Endocrine Dis, D-6900 Heidelberg, Germany
来源
NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES II, PROCEEDINGS | 2002年 / 966卷
关键词
catecholamine-induced cell death; B lymphocytes; rheumatoid arthritis;
D O I
10.1111/j.1749-6632.2002.tb04243.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The expression of beta(2)-adrenergic receptors (beta(2)-R) on B lymphocytes and agonist-induced cAMP production is reduced in patients with rheumatoid arthritis (RA). To further study functional consequences of the diminished beta(2)(-)R density on B lymphocytes in RA patients, agonist-induced cell death was evaluated and compared to healthy controls. B lymphocytes from patients with RA and healthy controls were activated with anti-IgM-antibody. Coincubation was carried out with isoprenaline (iso, 0.001-10 muM). Apoptotic and necrotic cells were determined using Annexin-V and propidium-iodide staining. beta(2)-R-induced cell death in B cells from healthy volunteers was stimulated after 24 h (medium, 21.2 +/- 1.6%; iso, 34.6 +/- 4.4%; increase 59.3 +/- 10.1%). However, in RA patients the increase in cell death following beta(2)-R stimulation (21.8 +/- 8.9%) was significantly impaired (p = 0.02). Our data demonstrate that catecholamine-induced cell death after stimulation of beta(2)-R on B lymphocytes is decreased in RA patients, possibly contributing to the pathogenesis of the disease.
引用
收藏
页码:425 / 428
页数:4
相关论文
共 8 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]   Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis [J].
Bergquist, J ;
Josefsson, E ;
Tarkowski, A ;
Ekman, R ;
Ewing, A .
ELECTROPHORESIS, 1997, 18 (10) :1760-1766
[3]  
Felten D., 1985, Journal of Immunology, V135, P755, DOI DOI 10.1002/JNR.490180108
[4]   BETA-ADRENERGIC RECEPTORS ON HUMAN SUPPRESSOR, HELPER, AND CYTOLYTIC LYMPHOCYTES [J].
KHAN, MM ;
SANSONI, P ;
SILVERMAN, ED ;
ENGLEMAN, EG ;
MELMON, KL .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (07) :1137-1142
[5]  
LOMO J, 1995, J IMMUNOL, V154, P1634
[6]   Interleukin-4 overcomes the negative influence of cyclic AMP accumulation on antigen receptor stimulated B lymphocytes [J].
Venkataraman, C ;
Chelvarajan, RL ;
Cambier, JC ;
Bondada, S .
MOLECULAR IMMUNOLOGY, 1998, 35 (14-15) :997-1014
[7]   Intracellular cAMP and β2-adrenergic receptors on CD19+lymphocytes in patients with rheumatoid arthritis [J].
Wahle, M ;
Krause, A ;
Kölker, S ;
von Wichert, P ;
Baerwald, CGO .
NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES, 1999, 876 :309-311
[8]   Impaired catecholaminergic signalling of B lymphocytes in patients with chronic rheumatic diseases [J].
Wahle, M ;
Kölker, S ;
Krause, A ;
Burmester, GR ;
Baerwald, CGO .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (05) :505-510